Fig. 2: Change from baseline in clinicopathological measures of response.

a, Bone marrow mast cells. b, Serum tryptase. c, KIT D816V variant allele fraction. d, Spleen volume. MC, mast cell.

a, Bone marrow mast cells. b, Serum tryptase. c, KIT D816V variant allele fraction. d, Spleen volume. MC, mast cell.